<DOC>
	<DOC>NCT00386750</DOC>
	<brief_summary>THIS STUDY IS NOT ENROLLING PATIENTS IN THE USA. To evaluate the effects of artemether/ lumefantrine on the auditory function.</brief_summary>
	<brief_title>Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Inclusion Criteria 12 years of age or older P. falciparum parasitemia between 50 and 100,000 parasites/μl History of fever or presence of fever (temperature ≥ 37.5°C) Exclusion Criteria Signs/symptoms of severe/complicated malaria Ingestion of various antimalarial drugs, or antibiotics in the previous 2 weeks to 2 months History of any drugrelated hearing impairment. Abnormal hearing function at study entry Exposure to sustained loud noises, by selfreport, within the past 24 hours. Present ear problems (Other protocoldefined inclusion/exclusion criteria may apply.)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Malaria</keyword>
	<keyword>hearing</keyword>
	<keyword>co-artemether</keyword>
	<keyword>auditory</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>marsh fever</keyword>
	<keyword>Plasmodium infections</keyword>
	<keyword>remittent fever</keyword>
	<keyword>paludism</keyword>
	<keyword>artemether</keyword>
	<keyword>artemisinins</keyword>
	<keyword>benflumetol</keyword>
	<keyword>lumefantrine</keyword>
</DOC>